U.S. administers over 415 million doses of COVID-19 vaccines - CDC
Reuters
Published Oct 26, 2021 05:23PM ET
Updated Oct 27, 2021 06:51AM ET
(Reuters) - The United States has administered 415,012,026 doses of COVID-19 vaccines in the country as of Tuesday morning and distributed 504,584,715 doses, the U.S. Centers for Disease Control and Prevention said.
Those figures are up from the 414,302,192 vaccine doses the CDC said had gone into arms by Oct. 25 out of 503,418,475 doses delivered.
The agency said 220,648,845 people had received at least one dose while 190,793,100 people were fully vaccinated as of 6:00 a.m. ET on Tuesday.
The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine.
About 13.8 million people have received a booster dose of either Pfizer (NYSE:PFE), Moderna or Johnson & Johnson's COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.